{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:48:03Z","timestamp":1785912483143,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB206137"],"award-info":[{"award-number":["20232BAB206137"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360735"],"award-info":[{"award-number":["82360735"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","award":["202410024"],"award-info":[{"award-number":["202410024"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cbi.2026.112190","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:44:55Z","timestamp":1780933495000},"page":"112190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Farnesoid X receptor and nuclear factor erythroid 2-related factor 2 synergistically ameliorate cholestatic liver injury by coordinating bile acid metabolism and transport"],"prefix":"10.1016","volume":"436","author":[{"given":"Lingye","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cbi.2026.112190_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s42255-022-00559-z","article-title":"Metabolic messengers: bile acids","volume":"4","author":"Perino","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cbi.2026.112190_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100530","article-title":"Mechanism of cholangiocellular damage and repair during cholestasis","volume":"26","author":"Salas-Silva","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"6","key":"10.1016\/j.cbi.2026.112190_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31613","article-title":"Improved markers of cholestatic liver injury in patients with primary biliary cholangitis treated with obeticholic acid and bezafibrate","volume":"73","author":"Smets","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cbi.2026.112190_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BST20210658","article-title":"Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders","volume":"50","author":"Molinaro","year":"2022","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.cbi.2026.112190_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2026.112190_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.cbi.2026.112190_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cbi.2026.112190_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1389200220666190426152830","article-title":"The role of the sodium-taurocholate Co-transporting polypeptide (NTCP) and bile salt export pump (BSEP) in related liver disease","volume":"20","author":"Xiaoyang","year":"2019","journal-title":"Curr. Drug Metabol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112190_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"issue":"17","key":"10.1016\/j.cbi.2026.112190_bib10","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism, cell","volume":"73","author":"Loboda","year":"2016","journal-title":"Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.cbi.2026.112190_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/00498254.2021.1880033","article-title":"Activation of Nrf2 decreases bile acid concentrations in livers of female mice","volume":"51","author":"Liu","year":"2021","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.cbi.2026.112190_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23151","article-title":"Nuclear factor erythroid 2\u2013related factor 2 is a positive regulator of human bile salt export pump expression","volume":"50","author":"Weerachayaphorn","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cbi.2026.112190_bib13","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1172\/JCI18945","article-title":"Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis","volume":"112","author":"Liu","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.cbi.2026.112190_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100919","article-title":"Selective agonism of liver and gut FXR prevents cholestasis and intestinal atrophy in parenterally fed neonatal pigs","volume":"66","author":"Jiang","year":"2025","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cbi.2026.112190_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153153","article-title":"Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor","volume":"68","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2026.112190_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173498","article-title":"Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo","volume":"885","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.cbi.2026.112190_bib17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/ptr.5431","article-title":"Paeoniflorin ameliorates ANIT-induced cholestasis by activating Nrf2 through an PI3K\/Akt-dependent pathway in rats","volume":"29","author":"Chen","year":"2015","journal-title":"Phytother Res."},{"issue":"7","key":"10.1016\/j.cbi.2026.112190_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/CS20220674","article-title":"Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr\/Nrf2 and CHOP-DR5-caspase-8 pathway","volume":"137","author":"Song","year":"2023","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cbi.2026.112190_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112664","article-title":"Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: role of NRF2 and FXR pathways","volume":"158","author":"Petrov","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.cbi.2026.112190_bib20","article-title":"Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis","volume":"1865","author":"Carino","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.cbi.2026.112190_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155124","article-title":"Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-\u03baB\/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress","volume":"122","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.cbi.2026.112190_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.29371","article-title":"\u03b2-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis","volume":"67","author":"Thompson","year":"2018","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cbi.2026.112190_bib23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/hep4.1746","article-title":"Cooperation between the NRF2 pathway and oncogenic \u03b2-catenin during HCC tumorigenesis","volume":"5","author":"Savall","year":"2021","journal-title":"Hepatol. Commun."},{"issue":"5","key":"10.1016\/j.cbi.2026.112190_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","article-title":"FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states","volume":"10","author":"Kemper","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.cbi.2026.112190_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154173","article-title":"Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis","volume":"102","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2026.112190_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154529","article-title":"NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury","volume":"108","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.cbi.2026.112190_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cbi.2026.112190_bib28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112190_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cbi.2026.112190_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11427-023-2353-0","article-title":"Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis","volume":"67","author":"Jia","year":"2024","journal-title":"Sci. China Life Sci."},{"issue":"6","key":"10.1016\/j.cbi.2026.112190_bib31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/ptr.6621","article-title":"Natural products for the prevention and treatment of cholestasis: a review","volume":"34","author":"Ma","year":"2020","journal-title":"Phytother Res."},{"issue":"1","key":"10.1016\/j.cbi.2026.112190_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","article-title":"Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases","volume":"24","author":"Yang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cbi.2026.112190_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101274","article-title":"NAFLD - a rising metabolic disease","volume":"50","author":"Zeigerer","year":"2021","journal-title":"Mol. Metabol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112190_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25074010","article-title":"Innovative molecular targets and therapeutic approaches in nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis (NAFLD\/NASH) 3.0","volume":"25","author":"Vairetti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9972","key":"10.1016\/j.cbi.2026.112190_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cbi.2026.112190_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-Related factor 2)","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.cbi.2026.112190_bib37","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/emboj.2012.150","article-title":"The many faces and functions of \u03b2-catenin","volume":"31","author":"Valenta","year":"2012","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.cbi.2026.112190_bib38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/jhep.2001.23786","article-title":"Changes in WNT\/beta-catenin pathway during regulated growth in rat liver regeneration","volume":"33","author":"Monga","year":"2001","journal-title":"Hepatology"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972600298X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972600298X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:07:10Z","timestamp":1785910030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972600298X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S000927972600298X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112190","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesoid X receptor and nuclear factor erythroid 2-related factor 2 synergistically ameliorate cholestatic liver injury by coordinating bile acid metabolism and transport","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112190"}}